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icked by application of pancreatic elastase to static endothe-
lial cells.  Conclusion: By inducing the release of an endothe-
lial elastase, shear stress induces an integrin-dependent re-
lease of FGF-2 from endothelial cells. 
 Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Fluid shear stress is probably the most significant 
physiological stimulus for endothelial cells to produce the 
endothelium-derived autacoids nitric oxide, prostacyclin 
and endothelium-derived hyperpolarizing factor  [1, 2] . 
Functionally, this shear stress-induced release of auta-
coids elicits a flow-dependent dilation allowing the acute 
adaptation of vascular conductivity to an augmented 
flow load. Moreover, shear stress controls the expression 
of various genes involved in autacoid synthesis and, in 
addition, cell survival, cell growth and cell cycle control 
 [3–5] . Consequently, shear stress is also a pivotal stimulus 
for structural arterial remodeling following chronic al-
teration of blood flow  [6–8] .
 Key Words 
 Shear stress   Mechanotransduction   Elastase   
Integrin   v  3   Fibroblast growth factor 2 
 Abstract 
 Background/Aims: Laminar shear stress is an important 
stimulus in the endothelium-dependent control of vascular 
tone and of vascular remodeling processes. Based on previ-
ous studies demonstrating integrin-mediated release of fi-
broblast growth factor 2 (FGF-2), we investigated whether 
shear stress-induced integrin activation requires the involve-
ment of an extracellular protease.  Methods: Cultured por-
cine aortic endothelial cells (PAEC) were exposed to laminar 
shear stress (16 dyn/cm 2 ), whereas static cells served as con-
trols.  Results:  Exposure of PAEC to shear stress led to an in-
creased activity of a protease in supernatants. This protease 
could be characterized as elastase but was different from 
neutrophil and pancreatic elastases. The enhanced activity 
was accompanied by the activation of integrin   v  3 and p38 
MAPK, and followed by an increased FGF-2 concentration in 
the supernatant. Pretreatment with inhibitors of either elas-
tase or integrin   v  3 resulted in a reduction of FGF-2 release. 
The observed effects of shear stress on integrin   v  3 and p38 
MAPK activation, as well as on FGF-2 release could be mim-
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 There is ample evidence that shear stress stimulates en-
dothelial cells via multiple pathways, involving the activa-
tion of ion channels, G protein-coupled receptors, inte-
grins as well as receptor tyrosine kinases, ultimately lead-
ing to the activation of mitogen-activated protein kinases 
(MAPK) and downstream transcription factors. Inte-
grins, membrane caveolae, receptor tyrosine kinases, G 
proteins, ion channels as well as glycocalyx components 
have been reported to act as mechanotransducers upon 
endothelial stimulation by shear stress  [9–11] . Consider-
ing that a mechanical deformation of the cells occurs dur-
ing exposure to shear forces, the cytoskeleton and its plas-
malemmal anchoring complexes also play a role in the 
mechanotransduction of shear stress  [12] . In particular, 
transmembrane proteins such as platelet endothelial cell 
adhesion molecule (PECAM-1) and integrins potentially 
act as mechanotransducers. With regard to integrins, 
there is evidence for inside-out signaling during shear 
stress which may support endothelial cell adherence 
 under conditions of elevated external forces. Indeed, 
PECAM-1, using vascular endothelial cell cadherin as an 
adaptor molecule, elicits activation of integrins in a clas-
sical inside-out manner  [13] . However, there is also evi-
dence that shear stress leads to outside-in integrin signal-
ing. Several reports on altered expression, activity and 
 release of metalloproteinases and cysteine proteases (ca-
thepsins L and K) under shear stress strongly suggest that 
modulation of the extracellular matrix (ECM) by these 
enzymes contributes to activation of cellular adhesion 
molecules as part of mechanotransduction  [14–17] . More-
over, a modulation of ECM protein expression under 
chronic shear stress has been reported  [18, 19] . Besides, 
various different ECM proteins or their fragments can 
lead to specific integrin and MAP kinase signaling during 
flow  [20] . Therefore, the production, composition and in 
particular the enzymatic modification of the ECM may be 
pivotal in the response of endothelial cells to shear stress. 
 We have shown previously that endothelial adhesion 
molecules, in particular laminin-binding protein and in-
tegrin   v  3 , mediate shear stress responses in cultured 
endothelial cells  [21, 22] . Laminin-binding protein has 
been shown to act as an essential mediator of shear stress-
induced endothelial nitric oxide synthase expression in 
porcine aortic endothelial cells. In addition, integrin 
  v  3 was found to be an integral part of the signaling cas-
cade leading to shear stress-induced release of fibroblast 
growth factor 2 (FGF-2) from endothelial cells, a poten-
tially significant process in flow-related vascular remod-
eling. However, the mechanism of integrin activation re-
mained unclear.
 Based on previous observations by others on the oc-
currence of proteases or their inhibitors during shear 
stress  [14–17] , we hypothesized that the activation of the 
integrin   v  3 , and hence the FGF-2 release, is due to the 
action of an endothelium-derived protease. Therefore, we 
studied potential alterations of matrix composition and 
of proteolytic activities in endothelial cell cultures ex-
posed to arterial levels of shear stress. Since we found 
evidence for the release of a yet unidentified elastase dur-
ing shear stress, we also studied whether exogenously ap-
plied elastase could mimic the effects of shear stress on 
integrin   v  3 activation and FGF-2 release in static endo-
thelial cells. 
 Methods 
 Unless stated otherwise, all reagents were purchased from Ap-
plichem. 
 Cell Culture 
 Porcine aortic endothelial cells (PAEC) were isolated as de-
scribed previously by Gloe et al.  [21] . Cells were cultured on stan-
dard plastic culture dishes in DMEM (Gibco) containing 10% FCS 
(Biochrom) and 1% of a mixture of amphotericin B, penicillin and 
streptomycin (Sigma). They were subcultured using trypsin/
EDTA (Sigma). Cultured cells were identified as endothelial cells 
by the presence of PECAM-1 antigen. PAEC at passages 3–5 were 
used in all experiments.
 Shear Stress Experiments 
 A laminar shear stress of 16 dyn/cm 2 was applied using a cone 
and plate apparatus as described before  [21] . Cells were trans-
ferred onto glass plates coated with collagen G (10   g/ml; Bio-
chrom). After 16 h, the medium was changed to DMEM (without 
phenol red; Sigma) containing 1% FCS. The inhibitors chymo-
statin (CHY; Sigma), methoxysuccinyl-Ala-Ala-Pro-Val-chloro-
methylketone (MEO; Bachem) and Abciximab (ABC; Lilly) were 
added 15 min prior to the exposure to shear stress and left in the 
medium throughout the experiment. Static controls were taken 
from the same culture and also grown on glass plates. Afterwards, 
the supernatant was collected for quantitative FGF-2 and elastase 
activity measurements. The cells were immediately lysed for 
Western blot analysis or fixed for immunofluorescence experi-
ments as described below. Protein extracts were frozen after prep-
aration and stored at –20   °   C until further analysis. Cell lysates 
were analyzed for equal protein levels using the bicinchoninic 
acid assay (Perbio).
 Assessment of FGF-2  
 FGF-2 in cell supernatants was measured using a commercial-
ly available ELISA kit (R&D Systems) according to the manufac-
turer’s instructions. Immunostaining of FGF-2 was performed as 
follows: PAEC were fixed with 3.7% formaldehyde, blocked using 
1% bovine serum albumin in PBS, and incubated with the pri-
mary FGF-2 antibody (Sigma) overnight at 4   °   C. The FITC-la-
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beled secondary antibody (Invitrogen) was applied for 30 min at 
room temperature. The samples were analyzed using a standard 
fluorescence microscope (Axiovert 200M; Zeiss). FGF-2 trans-
location to the cell surface was analyzed by flow cytometry 
 (FACScan; Becton Dickinson) using a FGF-2 primary antibody 
(Sigma) and an FITC-labeled secondary antibody (Invitrogen). 
Suspended cells were detached using a citrate buffer composed of 
135 m M KCl and 15 m M sodium citrate.
 Determination of Elastase Activity 
 Elastase activity measurements were performed using the spe-
cific substrate methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroaniline 
(MeOSuc-Ala-Ala-Pro-Val-pNA, 20   g/ml; Bachem). Fifty mi-
croliters of each sample was incubated with 1   l of substrate for 
30 min and absorbance detected using a spectrophotometer. A 
calibration curve for each individual set of experiments was gen-
erated using porcine pancreatic elastase.
 Zymography 
 Supernatants from cells exposed to shear stress and static con-
trols were analyzed by SDS-PAGE (gels supplemented with 10 mg/
ml gelatine) using denaturing but nonreducing conditions. SDS 
was removed from the gel by 3 subsequent washings with 2.5% 
Triton X-100 for 30 min each. Proteases were allowed to react with 
the gelatine in the gel for 16 h at 37  °   C in a bathing solution con-
taining 50 m M Tris (pH 7.5), 200 m M NaCl, 5 m M CaCl 2 and 0.02% 
Tween 20. Finally, the gel was stained with Coomassie blue G250 
(0.7 m M in 10% acetic acid) and destained (7% acetic acid in 5% 
methanol) until areas of proteolytic activity were detectable as 
white bands.
 Immunoblotting and Immunoprecipitation 
 The buffer used for cell lysis was composed as follows: 20 m M 
Tris, 137 m M NaCl, 2 m M EDTA (pH 8.0), 10% glycerol and 0.1% 
sodium deoxylcholate. The protease and phosphatase inhibitors 
aprotinin (10   g/ml), leupeptin (10   g/ml), phenylmethylsulfonyl 
fluoride (1 m M ), sodium fluoride (0.5 m M ) and sodium orthovan-
adate (0.5 m M ) were added to the buffer prior to each experiment. 
Protein content was assessed using a bicinchoninic acid assay 
(Perbio). Equal amounts of total protein were separated by SDS-
PAGE and transferred to a nitrocellulose membrane using stan-
dard techniques. The membrane was incubated overnight at 4  °  C 
with antibodies against neutrophil elastase (Santa Cruz), Shc (Up-
state), phospho-p38 (Cell Signaling), phospho-ERK1/ERK2 (Cell 
Signaling), GAPDH (Chemicon), p38 (Cell Signaling) and phos-
pho-Hsp27 (Cell Signaling). Incubation with the secondary anti-
body (Calbiochem) was performed subsequently for 1.5 h at room 
temperature. Protein bands were detected using a horseradish 
peroxide chemiluminescence detection kit.
 For immunoprecipitation cell lysates were incubated for 2 h at 
4   °   C with LM609 (Chemicon), an antibody to integrin   v  3 , and 
magnetic beads coated with protein G (Miltenyi Biotec). Precipi-
tates were separated using a magnetic separation unit (Miltenyi 
Biotec). Immunoblotting was performed as described above.
 Elastase Experiments 
 Static cells were treated with porcine pancreatic elastase (0.5 
U/ml; SERVA). The elastase was applied to the supernatant of stat-
ic endothelial cells for 5, 10, 30 or 60 min. Cells were then imme-
diately fixed or lysed as described above. MAP kinase inhibition 
was performed using the p38 MAPK inhibitor SB201290 (10   M ; 
Upstate) or U0126 (10   M ; Calbiochem) to block the activity of 
MEK1/2. These substances were added to the medium 30 min 
prior to elastase treatment.
 Statistical Analysis 
 All quantitative data are expressed as means  8 standard error 
of the mean. Statistical tests were performed using the SigmaStat 
statistic software (SPSS Inc.). If not stated otherwise, differences 
between treatment groups or changes over time were analyzed us-
ing one-way analysis of variance for repeated measures (ANOVA 
RM) followed by post hoc analysis using the Student Newman-
Keuls method. If data were not normally distributed, ANOVA 
RM on ranks was used but mean values are presented nevertheless 
for comparability of data. Representative immunoblots and fluo-
rescence images are shown. The number of experiments is indi-
cated in the figure legends. p values less than 0.05 were considered 
significant.
 Results 
 Effects of Shear Stress 
 An Elastase Is Released by Endothelial Cells after 
Exposure to Shear Stress 
 Zymographic analysis revealed a marked proteolytic 
activity at 28 kDa in supernatants from cells exposed to 
shear stress but not in static cells ( fig. 1 a). Supernatants of 
static and cells exposed to shear stress were additionally 
analyzed by immunoblotting using an antibody raised 
against neutrophil elastase. As in zymograms, a band was 
observed at 28 kDa only after shear stress exposure 
( fig. 1 b). To further characterize this protease activity we 
used the specific elastase substrate MeOSuc-Ala-Ala-Pro-
Val-pNA. Elastase activity in the supernatant of cells ex-
posed to shear stress was more than 3-fold higher than in 
the supernatant of static controls (static 0.06  8 0.01 U/
ml, shear 0.20  8 0.03 U/ml) ( fig. 1 c). An increase in elas-
tase activity could still be observed after pretreatment 
with ABC, an antibody fragment that blocks the integrin 
  v  3 (static + ABC 0.04  8 0.01 U/ml, shear + ABC 0.15 
 8 0.01 U/ml). To assess how quickly this protease is re-
leased, time course experiments were performed. Signif-
icantly increased elastase activity was already detectable 
after 5 min of exposure to shear stress. During the follow-
ing 30 min, the elastase concentration in the supernatant 
increased further, after which it reached a plateau ( fig. 1 d). 
In order to investigate whether neutrophil or pancreatic 
elastases are expressed in endothelial cells, we performed 
RT-PCR. However, neither neutrophil nor pancreatic 
elastases were revealed in endothelial cells at the mRNA 
level (data not shown).
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 Shear Stress-Induced FGF-2 Release Is Elastase 
Dependent 
 Shear stress not only increased elastase activity in the 
supernatant but also significantly augmented the con-
centration of FGF-2 in the supernatant more than 4-
fold (static 78.5  8 17.9 pg/ml, shear 365.5  8 45.1 pg/ml; 
 fig. 2 a), which is in line with our previous findings  [22] . 
This increase in FGF-2 concentration was partly an elas-
tase-dependent effect, since pretreatment with both the 
unspecific serine protease inhibitor CHY (10   g/ml, 
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 Fig. 1. Endothelial shear stress is associated with an increased 
elastase activity in the supernatant.  a Supernatants of static and 
cells exposed to 16 dyn/cm 2 shear stress (2 h) were analyzed by 
zymography (n = 3). White bands represent areas of protease ac-
tivity.  b Supernatants were analyzed by immunoblotting using an 
anti-neutrophil elastase antibody (n = 3).  c Enzymatic activity in 
supernatants was determined using MeOSuc-Ala-Ala-Pro-Val-
pNA (ABC, 1   g/ml; n = 20).  *  p  ! 0.05 vs. static, ANOVA RM on 
ranks, Student-Newman-Keuls. n.s. = Not significant.  d A sig-
nificant increase of elastase activity occurred already after 5 min 
of shear stress exposure (n = 4–6).  *  p  ! 0.05 vs. static. 
 Fig. 2. The effect of shear stress on FGF-2 release is dependent 
on elastase and the integrin   v  3 .  a PAEC were either left static 
or exposed to 16 dyn/cm 2 shear stress for 2 h. Serine protease 
inhibition was performed using CHY (10   g/ml), specific elas-
tase inhibition with MEO (50   M ) and integrin   v  3 was inhib-
ited with ABC (1   g/ml) (n = 7–12).  *  p  ! 0.001 vs. static;  †  p  ! 
0.05 vs. shear.  b FGF-2 immunofluorescence images of static 
cells and cells exposed to shear stress show a translocation of 
FGF-2 to the cell membrane (16 dyn/cm 2 , 2 h, n = 3). Scale bar = 
10   m.  ! 63. 
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shear + CHY 205.3  8 33.7 pg/ml) as well as the specific 
elastase inhibitor MEO (shear + MEO 250.8  8 48.2 pg/
ml) significantly attenuated the shear stress-induced 
FGF-2 increase. In accordance with our earlier study  [22] , 
blocking the integrin   v  3 with ABC abolished the in-
crease in FGF-2 in supernatants during shear stress (shear 
+ ABC 124.9  8 8.4 pg/ml;  fig. 2 a).
 Immunofluorescence labeling of static cells showed 
FGF-2 mainly in nuclear and perinuclear regions. In con-
trast, shear stress-treated cells additionally exhibited ag-
gregate-like staining of FGF-2 at the plasma membrane, 
suggesting that part of the intracellular FGF-2 had been 
redistributed towards the membrane for release upon 
shear stress exposure ( fig. 2 b).
 Shear Stress-Induced Integrin   v  3 Activation Is 
Elastase Dependent 
 To determine whether the activation state of the inte-
grin   v  3 was affected by shear stress exposure, we mea-
sured the association of this integrin with its adaptor pro-
tein Shc ( fig. 3 a). After PAEC exposure to shear stress, the 
46- and 52-kDa Shc isoforms showed a significantly high-
er association with integrin   v  3 than static controls 
(shear: 46 kDa, 1.6  8 0.3-fold; 52 kDa, 1.8  8 0.3-fold). 
The specific elastase inhibitor MEO significantly reduced 
the interaction of the integrin and the Shc isoform of 52 
kDa (shear + MEO: 46 kDa, 1.3  8 0.3-fold; 52 kDa, 1.3 
 8 0.2-fold over the static controls;  fig. 3 b).
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 Fig. 3. Elastase inhibition decreases shear stress-induced integrin 
  v  3 and p38 MAPK activation.  a ,  b PAEC lysates were subjected 
to immunoprecipitation (IP) with an   v  3 antibody and immu-
noblotted against Shc. Cell lysates were separately immuno-
blotted for Shc and GAPDH to confirm equal protein loading.
 a Shear stress (16 dyn/cm 2 ) induced a sustained increase in the 
association of integrin   v  3 with Shc (n = 3).  b Elastase inhibition 
(MEO, 50   M ) reduced this interaction (16 dyn/cm 2 , 1 h; n = 4). 
 *  p  ! 0.05 vs. static;  †  p  ! 0.05 vs. shear.  c Static PAEC or cells ex-
posed to 16 dyn/cm 2 shear stress were analyzed for p38 MAPK 
and ERK activation by immunoblotting (n = 3).  d Elastase activ-
ity was inhibited using MEO (50   M ) or CHY (10   g/ml). The 
integrin   v  3 was blocked with ABC (1   g/ml) (n = 3). GAPDH 
was used to control equal protein loading. 
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 Fig. 4. Elastase induces the release of FGF-2.  a PAEC were stimu-
lated with porcine pancreatic elastase (0.5 U/ml). Supernatants 
were collected for quantitative analysis of FGF-2 (n = 6).  *  p  ! 0.05 
vs. control.  b FGF-2 immunofluorescence staining of untreated 
or elastase-stimulated PAEC show a similar translocation as ob-
served under shear stress (2 h, n = 3). Scale bar = 10   m.  ! 63.
 c PAEC were left untreated or stimulated with porcine pancreatic 
elastase (ELA, 0.5 U/ml), heparinase (HEP, 0.5 U/ml) or both 
(ELA + HEP) for 60 min. Supernatants were analyzed for FGF-2 
levels (n = 12 and n = 6 for ELA + HEP).  *  p  ! 0.05 vs. control;
 †  p  ! 0.05 vs. ELA. The inhibitory effect of different MEO concen-
trations on various elastase concentrations (n = 3, representative 
graphs are shown) ( d ) or 0.5 U/ml elastase (n = 3,  *  p  ! 0.05 vs. 
w/o) ( e ) correlated with its effect on elastase (0.5 U/ml)-induced 
FGF-2 release (n = 5) ( f ).  *  p  ! 0.05 vs. control;  †  p  ! 0.05 vs. elas-
tase w/o. 
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 Shear Stress-Induced p38 MAPK Activation Is 
Blocked by Elastase Inhibition 
 Shear stress application to PAEC resulted in an en-
hanced phosphorylation of p38 MAPK and ERK1/2 
( fig. 3 c). The inhibition of elastase with both the specific 
inhibitor MEO as well as the unspecific inhibitor CHY 
prevented the shear stress-induced p38 MAPK phosphor-
ylation but not ERK1/2 activation. The integrin   v  3 
blocker ABC also reduced the activation of p38 MAPK 
( fig. 3 d). In contrast, the phosphorylation of ERK1/2 was 
not reduced after inhibition of elastase or the integrin 
  v  3 in cells exposed to shear stress. Neither of the in-
hibitors affected p38 MAPK and ERK1/2 phosphoryla-
tion levels in static control cells.
 Effects of External Elastase on Static Cells 
 Elastase Treatment Induces an Increase in FGF-2 in 
the Supernatant 
 Since the data obtained in this study suggest that an 
endogenous, as yet not molecularly characterized elas-
tase plays a causal role in the shear stress-induced in-
crease in the extracellular concentration of FGF-2, we 
further investigated whether external elastase treat-
ment could mimic this effect in non-shear-stressed 
cells. For this purpose, static PAEC were treated with 
0.5 U/ml of porcine pancreatic elastase. Application of 
elastase for 5, 10, 30 or 60 min increased the concentra-
tion of FGF-2 in the supernatant in a time-dependent 
manner, reaching a significant difference after 60 min 
[control 63.2  8 12.0 pg/ml, elastase (60 min) 161.7  8 
21.4 pg/ml;  fig.  4 a]. Immunofluorescence revealed a 
similar translocation of FGF-2 to the cell membrane as 
observed under shear stress ( fig. 4 b). As measured by 
flow cytometry, elastase did not induce FGF-2 release 
from endothelial cells kept in suspension: whereas there 
was a significant translocation of FGF-2 to the cell sur-
face in cells attached to their matrix by 50% relative to 
control values (control 1.00  8 0.05 vs. elastase 1.50  8 
0.15, n = 13, p = 0.005), the same treatment was without 
effect in cells kept in suspension (control 1.00  8 0.10 vs. 
elastase 1.00  8 0.07, n = 7).
 In contrast to the treatment with elastase, treatment 
with heparinase I (0.5 U/ml) for 60 min did not alter the 
concentration of FGF-2 in the supernatant (control 35.8 
 8 5.3 pg/ml vs. heparinase 39.5  8 5.8 pg/ml). Hepari-
nase I cleaves heparin and heparan sulfates on the cell 
membrane, known to be extracellular binding sites for 
FGF-2  [23] . Simultaneous application of elastase and hep-
arinase did not further increase the FGF-2 concentration 
in the supernatant when compared to elastase treatment 
alone (elastase 124.3  8 10.6 pg/ml vs. elastase + hepari-
nase 128.7  8 16.2 pg/ml;  fig. 4 c).
 MEO inhibited the activity of pancreatic elastase in a 
concentration-dependent manner. Total inhibition of 
elastase activity was achieved using 5 or 50   M of the in-
hibitor ( fig. 4 d, e). The inhibitory effect of different con-
centrations of MEO on the elastase activity correlated 
well with its inhibitory effects on FGF-2 release ( fig. 4 f).
 Elastase Treatment Activates the Integrin   v  3 
 Similar to our findings with shear stress, treatment 
with porcine pancreatic elastase induced an enhanced 
interaction of the integrin   v  3 with Shc, as revealed by 
co-immunoprecipitation. Already 10 min after the on-
set of elastase treatment a significantly higher amount 
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 Fig. 5. Elastase increases the association between Shc and the in-
tegrin   v  3 . PAEC were time-dependently stimulated with elas-
tase (0.5 U/ml). Lysates were subjected to immunoprecipitation 
(IP) with an   v  3 antibody and immunoblotted against Shc
(n = 3).  *  p  ! 0.05 vs. control. Same lysates were separately immu-
noblotted for Shc and GAPDH to check equal protein loading. 
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of the Shc isoforms was associated with the integrin 
[elastase (10 min): 46 kDa, 2.6  8 0.6-fold; 52 kDa, 1.7 
 8 0.2-fold over controls]. This interaction was main-
tained over 60 min of elastase treatment [elastase (60 
min): 46 kDa, 1.9  8 0.5-fold; 52 kDa, 1.6  8 0.2-fold over 
controls;  fig. 5 ].
 Pharmacological Inhibition of p38 MAPK Blocks 
Elastase-Induced FGF-2 Release 
 To analyze whether elastase treatment activated MAP 
kinases in a similar manner as shear stress, p38 MAPK 
and ERK activation was analyzed. Application of porcine 
pancreatic elastase led to an increased phosphorylation of 
both p38 MAPK and ERK in a time-dependent manner 
( fig. 6 a).
 To study the impact of MAP kinase activation on the 
elastase-induced FGF-2 release, cells were treated with 
the specific inhibitors SB202190 (for p38 MAPK) or 
U0126 (for MEK1/2). The effective inhibition was moni-
tored by Western blot analysis. The effect of SB202190 
was examined by analyzing the phosphorylation of 
Hsp27, a downstream target of p38. Whereas p38 MAPK 
inhibition significantly reduced the FGF-2 increase in the 
supernatant (to 57  8 15%), ERK inhibition had no influ-
ence on the elastase-induced release of this growth factor 
( fig. 6 b).
 Discussion 
 The main finding of this study is that shear stress in-
duces integrin activation and FGF-2 release partly via a 
novel protease-dependent pathway. Due to its design, 
which focused on the comparability with our own earlier 
study  [22] and others  [24–26] , the experiments cannot 
answer the question whether this protease activation re-
quired a minimum level of shear stress or whether the 
protease release would have gradually changed with dif-
ferent levels of shear stress.
 However, our results clearly show that exposure of 
resting endothelial cells to arterial levels of laminar shear 
stress results in an enhanced enzymatic activity in their 
supernatant that can be characterized as an elastase. An 
increased concentration of this elastase was already mea-
surable after 5 min of shear stress application, indicating 
that the endothelium is able to respond very quickly to 
increased levels of flow. The enzyme is, however, different 
from pancreatic and neutrophil elastases and other pro-
teases with elastolytic activity. This elastase mediates the 
shear stress-induced activation of the integrin   v  3 and 
subsequently of the p38 MAPK pathway, leading to the 
release of FGF-2. Furthermore, we were able to demon-
strate that treatment of PAEC with exogenously applied 
porcine pancreatic elastase induced virtually the same ef-
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 Fig. 6. Elastase causes activation of p38 MAPK and ERK. P38 
MAPK inhibition decreases elastase-induced FGF-2 release.
 a Treatment with porcine pancreatic elastase activates p38 MAPK 
(n = 6) and ERK (n = 6). Equal protein loading was confirmed with 
total p38 MAPK and GAPDH.  b PAEC were treated with the p38 
MAPK inhibitor SB202190 (SB) or the MEK1/2 inhibitor U0126 
(U0) (10   M each). Cell supernatants were analyzed for FGF-2 re-
lease using an ELISA (n = 12, ANOVA RM on ranks, Student-
Newman-Keuls)  *  p  ! 0.05 vs. elastase. Immunoblotting of cell 
lysates was performed to confirm inhibitory effects of the phar-
macological substances used. Since SB202190 does not block p38 
MAPK phosphorylation directly, the activation of the down-
stream target protein Hsp27 was studied instead. Equal protein 
loading was controlled with GAPDH. 
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fects as observed under shear stress. The present study 
extends previous work from our laboratory demonstrat-
ing that shear stress induces the release of FGF-2 from 
endothelial cells  [22] . This process was found to be spe-
cifically dependent on the integrin   v  3 but the connec-
tion between shear stress and integrin activation re-
mained unclear.
 The endothelial FGF-2 release was reduced by the elas-
tase inhibitor MEO which is specific for enzymes of the 
elastase family  [27] . Moreover, the substrate MeOSuc-
Ala-Ala-Pro-Val-pNA, also considered to be specific for 
neutrophil and pancreatic elastase, was cleaved by this 
enzyme  [28, 29] . The presence of enzymes which have an 
elastolytic activity in intact vessels has been reported pre-
viously: Hornebeck et al.  [30] isolated an elastase from pig 
aortas that exhibited an elastolytic activity similar to 
pancreatic elastase. It is unlikely, however, that the en-
zyme is identical with neutrophil and pancreatic elastase, 
since we found no transcripts of these elastases in our 
cells. Of note, the specific substrate is not cleaved by oth-
er proteases, like cathepsins or MMPs, which previously 
also have been found to be activated, released or inhibited 
after shear stress exposure  [15, 16] . Thus, the involvement 
of proteases from the cathepsin and MMP family can be 
excluded in the present setting. Although some of these 
proteases also cleave elastin and can therefore be termed 
elastolytic enzymes, the activity of the endothelial en-
zyme which we detected was comparable solely to neutro-
phil and pancreatic elastase because they, in contrast to 
the other elastolytic enzymes, degrade the same specific 
substrate. Therefore, we propose that this endothelial ser-
ine protease with true elastase activity is a not yet de-
scribed mediator of endothelial shear stress responses. 
The major evidence for this conclusion is the following: 
(1) susceptibility to specific elastase inhibitors, (2) cleav-
age of the specific elastase substrate and (3) appropriate 
molecular weight.
 The characterization of the enzyme as an elastase 
based on the specific substrate does not mean that elastin 
is the only matrix protein targeted by the enzyme. Neu-
trophil elastase, for example, has a broad spectrum of ma-
trix substrates such as collagens, fibronectin, laminin 
and proteoglycans, and also cleaves some cytokines  [31, 
32] . Further studies are required to identify the matrix 
effects of the endothelial elastase in more detail and also 
to clarify whether its activity in the intact vessel wall is 
further controlled by serine protease inhibitors. There-
fore, the mechanism of action of the elastase needs fur-
ther characterization. Presently, it is unknown whether 
the elastase is acutely released in its active form from the 
endothelium in response to shear stress or whether it is 
activated by another enzyme or signal. Since shear stress 
still increased elastase activity when integrin   v  3 was 
blocked, we can exclude that the elastase release is prefer-
entially due to a direct activation of the integrin   v  3 by 
shear forces.
 As we were currently not able to identify the exact 
nature of the endothelial elastase which also precluded 
silencing of the respective gene, we sought to support 
our conclusions by comparing the effects of shear stress 
with those in response to exogenously applied pancre-
atic elastase. Although this enzyme most likely does not 
possess an identical substrate spectrum, the consistency 
of the findings was remarkable. Both treatments in-
duced activation of the integrin   v  3 and p38 MAPK 
and, as a consequence, increased FGF-2 levels in the su-
pernatant. A similar pancreatic elastase-mediated re-
lease of FGF-2 has previously been described in cultures 
p38
FGF-2
Shear
stress
Endothelial cells
ECM
ERK
Elastase
Integrin
Elastase
SHC
v 3 3v
 Fig. 7. Proposed model for shear stress-induced FGF-2 release 
from endothelial cells. Shear stress induces the release of an en-
dothelial elastase, activating integrin   v  3 outside-in signaling 
and thereby intracellular signaling cascades. FGF-2 is released via 
p38 MAPK. 
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of pulmonary fibroblasts. Based on the correlation of 
FGF-2 release with the liberation of sulfated glycosami-
noglycans, known to be extracellular binding sites for 
FGF-2, the authors concluded that FGF-2 was released 
by proteolytic digestion from proteoglycan storage sites 
in the ECM  [33, 34] . In another study, cultured pulmo-
nary smooth muscle cells treated with neutrophil elas-
tase also released FGF-2 from ECM storage sites  [35] . In 
contrast, our previous studies have shown that the shear 
stress-induced increase in extracellular FGF-2 corre-
sponds with a reduction in intracellular FGF-2  [22] . 
Moreover, we demonstrated that the increase in FGF-2 
is critically dependent on activation of the integrin   v  3 
and requires the activation of p38 MAPK. The need of 
these steps can hardly be explained by the ‘mere’ enzy-
matic liberation of matrix-bound FGF-2 in our experi-
ments. At present it is difficult to reconcile these appar-
ently contradictory findings. It is possible, however, that 
the amount of bound FGF-2 is much higher in the ECM 
and on the surface of pulmonary fibroblasts and smooth 
muscle cells than in endothelial cells, especially since the 
fibroblasts were cultivated for 10–12 days  [33] . In this 
case, an additional release from the cells may be less sig-
nificant as observed in the present study. In our experi-
ments, the cells were seeded on pure matrices or even 
plastic so that the only possible source for FGF-2 could 
have been the endothelial cells. Moreover, no extracel-
lular FGF-2 was detected outside the cells by immuno-
histochemistry after 1 day of culture. Furthermore, 
since heparinase I, known to release extracellularly 
bound FGF-2 by inhibiting FGF-2 binding to heparan 
sulfate proteoglycans  [36] , failed to increase the FGF-2 
concentration in the supernatant in our study, it is likely 
that matrix binding in our cell cultures was relatively 
low.
 The current study demonstrates that shear stress in-
duces the activation of the integrin   v  3 as assessed by 
its enhanced interaction with the adaptor protein Shc. 
This was reduced when the cells were pre-incubated 
with the specific elastase inhibitor, indicating that elas-
tase is a critical mediator of the activation. Of note, the 
exogenously applied pancreatic elastase induced a simi-
lar interaction of integrin   v  3 and Shc. Jalali et al.  [25] 
have previously demonstrated that shear stress increases 
the association of the integrin   v  3 and Shc in endothe-
lial cells. Likewise, Tzima et al.  [26] could show that 
shear stress activates the integrin   v  3 in endothelial 
cells using an antibody that selectively detects the acti-
vated integrin   v  3 . Our studies now provide a mecha-
nism of shear stress-induced integrin activation that is 
independent of a direct mechanical activation by shear 
forces. 
 Although it has been shown that platelet integrins may 
be activated by direct cleavage by elastase  [37] , this is un-
likely to have occurred in our study. Firstly, we did not 
find any change in the size of the integrin   v -subunit af-
ter exposure to pancreatic elastase and, secondly, elastase 
did not induce FGF-2 release from endothelial cells kept 
in suspension without any contact with the matrix. This 
is in agreement with a previous report stating that endo-
thelial cells must be anchored to the matrix in order to 
record and quantify cellular responses to mechanical 
strain  [38] . Thus, we suggest an elastase-induced remod-
eling of the ECM architecture as the activating mecha-
nism. Elastase-induced changes in the structure and ri-
gidity of the matrix is likely to enable new (or re-) cluster-
ing of integrins into focal adhesion points, a model which 
has been proposed previously  [39] . Alternatively, proteo-
lytic activities may expose hidden protein sequences or 
even release matrix fragments that have integrin-activat-
ing properties  [40, 41] . Previous investigations indicate 
that proteases are able to generate signals by remodeling 
the ECM  [42–44] .
 Our results further demonstrate that p38 MAPK and 
ERK were activated by shear stress exposure. Elastase in-
hibition reduced the shear stress-induced p38 MAPK ac-
tivation. Likewise, we were able to show that elastase 
treatment also induced activation of p38 MAPK and 
ERK. Moreover, we demonstrated that p38 MAPK but 
not ERK inhibition reduced the elastase-induced FGF-2 
release. Therefore, p38 MAPK seems to play a role in 
shear stress-induced FGF-2 release.
 Since several groups have demonstrated that inhibi-
tion of the integrin   v  3 blocked the activation of p38 
MAPK  [45, 46] , it is reasonable to argue that flow-in-
duced MAPK phosphorylation is mediated via this inte-
grin. This is in agreement with results reported by Chen 
et al.  [47] showing that direct inhibition of   v integrins 
or downregulation of their expression decreased the ac-
tive level of p38 MAPK. The precise signaling pathway 
connecting the integrin and MAP kinase activation is 
still elusive in our setting. However, since shear stress 
and elastase stimulation induced the association of the 
integrin with its adaptor protein Shc, downstream sig-
naling may be transduced via Shc and focal adhesion 
signaling.
 In conclusion, the present results support a new mod-
el for the translation of mechanical stress into biochemi-
cal signals via a novel endothelial elastase ( fig. 7 ). Since 
FGF-2 is an important growth factor in vascular develop-
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ment and maintenance, this model could have profound 
implications for our understanding of mechanically in-
duced vascular remodeling processes. The precise mech-
anisms by which elastase activates the integrin   v  3 and 
downstream signaling will be the focus of further inves-
tigations.
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